4 active not recruiting. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 4 |
| Phase 2 | 3 | Active not recruiting 3 |
Follow Urticaria: new trials by email Literature Review of Urticaria trials Research Report on Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Single Dose of LP-003 in Healthy Adult Subjects LP-003 200mg, Placebo - Chronic Spontaneous Urticaria | Phase 1 | Active not recruiting | Longbio Pharma | 12 | 2024-10-23 | 2025-12-18 |
| Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients ADX-324, Placebo - Hereditary Angioedema | Phase 1 / Phase 2 | Active not recruiting | ADARx Pharmaceuticals, Inc. | 53 | 2022-12-14 | 2026-06-16 |
| A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331 - Hereditary Angioedema, HAE | Phase 1 / Phase 2 | Active not recruiting | BioMarin Pharmaceutical | 44 | 2022-02-15 | 2024-05-16 |
| NTLA-2002 in Adults With Hereditary Angioedema (HAE) Biological NTLA-2002, Normal Saline IV Administration - Hereditary Angioedema | Phase 1 / Phase 2 | Active not recruiting | Intellia Therapeutics | 37 | 2021-12-10 | 2026-09-25 |
Angioedemas, Hereditary (3) · Chronic Urticaria (1)
Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Angioedema (3) · Cardiovascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hereditary Complement Deficiency Diseases (3) · Immunologic Deficiency Syndromes (3) · Primary Immunodeficiency Diseases (3) · Vascular Diseases (3)
RNA, Small Interfering (1) · Sodium Chloride (1)
ADARx Pharmaceuticals, Inc. (1) · BioMarin Pharmaceutical (1) · Intellia Therapeutics (1) · Longbio Pharma (1)
Australia (3) · China (1) · France (1) · Germany (1) · Netherlands (1) · New Zealand (1) · Spain (1) · United Kingdom (1) · United States (1)